These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28555315)

  • 1. Differential efficacies of the nicotinic α4β2 desensitizing agents in reducing nicotine self-administration in female rats.
    Rezvani AH; Slade S; Wells C; Yenugonda VM; Liu Y; Brown ML; Xiao Y; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2017 Sep; 234(17):2517-2523. PubMed ID: 28555315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats.
    Levin ED; Rezvani AH; Xiao Y; Slade S; Cauley M; Wells C; Hampton D; Petro A; Rose JE; Brown ML; Paige MA; McDowell BE; Kellar KJ
    J Pharmacol Exp Ther; 2010 Mar; 332(3):933-9. PubMed ID: 20007754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats.
    Johnson JE; Slade S; Wells C; Petro A; Sexton H; Rezvani AH; Brown ML; Paige MA; McDowell BE; Xiao Y; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2012 Jul; 222(2):269-76. PubMed ID: 22297831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain.
    Hussmann GP; Turner JR; Lomazzo E; Venkatesh R; Cousins V; Xiao Y; Yasuda RP; Wolfe BB; Perry DC; Rezvani AH; Levin ED; Blendy JA; Kellar KJ
    J Pharmacol Exp Ther; 2012 Nov; 343(2):441-50. PubMed ID: 22899752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral sazetidine-A, a selective α4β2* nicotinic receptor desensitizing agent, reduces nicotine self-administration in rats.
    Rezvani AH; Wells C; Slade S; Xiao Y; Kellar KJ; Levin ED
    Pharmacol Biochem Behav; 2019 Apr; 179():109-112. PubMed ID: 30794849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α4β2 Nicotinic receptor desensitizing compounds can decrease self-administration of cocaine and methamphetamine in rats.
    Levin ED; Rezvani AH; Wells C; Slade S; Yenugonda VM; Liu Y; Brown ML; Xiao Y; Kellar KJ
    Eur J Pharmacol; 2019 Feb; 845():1-7. PubMed ID: 30529197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.
    Hussmann GP; DeDominicis KE; Turner JR; Yasuda RP; Klehm J; Forcelli PA; Xiao Y; Richardson JR; Sahibzada N; Wolfe BB; Lindstrom J; Blendy JA; Kellar KJ
    J Neurochem; 2014 May; 129(4):721-31. PubMed ID: 24422997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats.
    Rezvani AH; Slade S; Wells C; Petro A; Lumeng L; Li TK; Xiao Y; Brown ML; Paige MA; McDowell BE; Rose JE; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2010 Aug; 211(2):161-74. PubMed ID: 20535453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutually augmenting interactions of dextromethorphan and sazetidine-A for reducing nicotine self-administration in rats.
    Levin ED; Wells C; Slade S; Rezvani AH
    Pharmacol Biochem Behav; 2018 Mar; 166():42-47. PubMed ID: 29407477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats.
    Paterson NE; Min W; Hackett A; Lowe D; Hanania T; Caldarone B; Ghavami A
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1455-64. PubMed ID: 20708056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic sazetidine-A, a selective α4β2 neuronal nicotinic acetylcholine receptors desensitizing agent on pharmacologically-induced impaired attention in rats.
    Rezvani AH; Cauley M; Xiao Y; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2013 Mar; 226(1):35-43. PubMed ID: 23100170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sazetidine-A, a selective α4β2* nicotinic receptor desensitizing agent, on body temperature regulation in mice and rats.
    Rezvani AH; Timofeeva O; Sexton HG; DeCuir D; Xiao Y; Gordon CJ; Kellar KJ; Levin ED
    Eur J Pharmacol; 2012 May; 682(1-3):110-7. PubMed ID: 22387853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.
    Liu X
    Psychopharmacology (Berl); 2013 Nov; 230(2):203-13. PubMed ID: 23712602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator NS9283.
    Maurer JJ; Sandager-Nielsen K; Schmidt HD
    Psychopharmacology (Berl); 2017 Feb; 234(3):475-484. PubMed ID: 27844094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice.
    Tobey KM; Walentiny DM; Wiley JL; Carroll FI; Damaj MI; Azar MR; Koob GF; George O; Harris LS; Vann RE
    Psychopharmacology (Berl); 2012 Sep; 223(2):159-68. PubMed ID: 22526534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of effects produced by nicotine and the α4β2-selective agonist 5-I-A-85380 on intracranial self-stimulation in rats.
    Freitas K; Carroll FI; Negus SS
    Exp Clin Psychopharmacol; 2016 Feb; 24(1):65-75. PubMed ID: 26461167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic effects of Sazetidine-A, a new nicotinic cholinergic drug.
    Cucchiaro G; Xiao Y; Gonzalez-Sulser A; Kellar KJ
    Anesthesiology; 2008 Sep; 109(3):512-9. PubMed ID: 18719450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of administration of the nicotinic acetylcholine receptor antagonist BTMPS, during nicotine self-administration, on lever responding induced by context long after withdrawal.
    Hall BJ; Pearson LS; Buccafusco JJ
    Neuropharmacology; 2010 Feb; 58(2):429-35. PubMed ID: 19772864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats.
    Rezvani AH; Cauley M; Sexton H; Xiao Y; Brown ML; Paige MA; McDowell BE; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2011 Jun; 215(4):621-30. PubMed ID: 21274704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adolescent vs. adult-onset nicotine self-administration in male rats: duration of effect and differential nicotinic receptor correlates.
    Levin ED; Lawrence SS; Petro A; Horton K; Rezvani AH; Seidler FJ; Slotkin TA
    Neurotoxicol Teratol; 2007; 29(4):458-65. PubMed ID: 17433619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.